1-4 of 4
Norman F Russkamp
Close
Sort by
Journal Articles

A Bispecific Antibody Targeting CD117 and CD3 Enables T Cell Mediated Killing of CD117-Expressing Healthy and Malignant Hematopoietic Cells

Jonathan D Kiefer, Renier Myburgh, Norman F Russkamp, Laura Volta, Adrian Guggisberg, Omar Abdelmotaleb, Jacqueline Mock, Dario Neri, Markus G Manz
Journal: Blood
Blood (2021) 138 (Supplement 1): 2354.
https://doi.org/10.1182/blood-2021-147676
Published: 2021
Journal Articles

Anti-CD117 CAR T Cells Incorporating a Safety Switch Eradicate Acute Myeloid Leukemia and Deplete Human Hematopoietic Stem Cells

Chiara F Magnani, Renier Myburgh, Norman F Russkamp, Steve Pascolo, Judith A Shizuru, Dario Neri, Markus G Manz
Journal: Blood
Blood (2021) 138 (Supplement 1): 2808.
https://doi.org/10.1182/blood-2021-145195
Published: 2021
Journal Articles

Selective CD117 + HSC exchange therapy

Markus G. Manz, Norman F. Russkamp
Journal: Blood
Blood (2019) 133 (19): 2007–2009.
https://doi.org/10.1182/blood-2019-03-900894
Published: 2019
Journal Articles

Anti-Human CD117 CAR T-Cells Efficiently Eliminate Hematopoietic Stem and CD117-Positive AML Cells

Renier Myburgh, PhD BSc, MSc, Jonathan Kiefer, Msc, Norman F Russkamp, Dr. MD, Alexander Simonis, Dr. MD, Surema Pfister, C. Matthias Wilk, MD, Chiara Magnani, PhD, Antonia MS Mueller, MD, Burkhard Becher, Prof. Dr., Maries van den Broek, Prof. Dr., Dario Neri, Prof. Dr., Markus G. Manz, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4063.
https://doi.org/10.1182/blood-2018-99-118230
Published: 2018